120 related articles for article (PubMed ID: 21405942)
1. A comparison of chitosan-silica and sodium starch glycolate as disintegrants for spheronized extruded microcrystalline cellulose pellets.
Goyanes A; Souto C; Martínez-Pacheco R
Drug Dev Ind Pharm; 2011 Jul; 37(7):825-31. PubMed ID: 21405942
[TBL] [Abstract][Full Text] [Related]
2. Chitosan-kaolin coprecipitate as disintegrant in microcrystalline cellulose-based pellets elaborated by extrusion-spheronization.
Goyanes A; Souto C; Martínez-Pacheco R
Pharm Dev Technol; 2013 Feb; 18(1):137-45. PubMed ID: 22309024
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the utility of two superdisintegrants in microcrystalline cellulose pellets prepared by extrusion-spheronization.
Souto C; Rodríguez A; Parajes S; Martínez-Pacheco R
Eur J Pharm Biopharm; 2005 Sep; 61(1-2):94-9. PubMed ID: 15967651
[TBL] [Abstract][Full Text] [Related]
4. Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization.
Goyanes A; Souto C; Martínez-Pacheco R
Pharm Dev Technol; 2010 Dec; 15(6):626-35. PubMed ID: 20148708
[TBL] [Abstract][Full Text] [Related]
5. New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization.
Goyanes A; Martínez-Pacheco R
Drug Dev Ind Pharm; 2015 Mar; 41(3):362-8. PubMed ID: 24279425
[TBL] [Abstract][Full Text] [Related]
6. Co-processed MCC-Eudragit® E excipients for extrusion-spheronization.
Goyanes A; Souto C; Martínez-Pacheco R
Eur J Pharm Biopharm; 2011 Nov; 79(3):658-63. PubMed ID: 21827853
[TBL] [Abstract][Full Text] [Related]
7. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
Mehta S; De Beer T; Remon JP; Vervaet C
Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
[TBL] [Abstract][Full Text] [Related]
8. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
9. Extruded and spheronized beads containing no microcrystalline cellulose: influence of formulation and process variables.
Agrawal AM; Howard MA; Neau SH
Pharm Dev Technol; 2004; 9(2):197-217. PubMed ID: 15202579
[TBL] [Abstract][Full Text] [Related]
10. Influence of chitosan type on the properties of extruded pellets with low amount of microcrystalline cellulose.
Charoenthai N; Kleinebudde P; Puttipipatkhachorn S
AAPS PharmSciTech; 2007 Aug; 8(3):E64. PubMed ID: 17915814
[TBL] [Abstract][Full Text] [Related]
11. Multiple sources of sodium starch glycolate, NF: evaluation of functional equivalence and development of standard performance tests.
Shah U; Augsburger L
Pharm Dev Technol; 2002; 7(3):345-59. PubMed ID: 12229266
[TBL] [Abstract][Full Text] [Related]
12. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; Remon JP; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2007 Nov; 67(3):715-24. PubMed ID: 17537625
[TBL] [Abstract][Full Text] [Related]
13. Development of polymer-bound fast-dissolving metformin buccal film with disintegrants.
Haque SE; Sheela A
Int J Nanomedicine; 2015; 10 Suppl 1(Suppl 1):199-205. PubMed ID: 26491321
[TBL] [Abstract][Full Text] [Related]
14. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
Young CR; Koleng JJ; McGinity JW
J Microencapsul; 2003; 20(5):613-25. PubMed ID: 12909545
[TBL] [Abstract][Full Text] [Related]
15. Effects of modification and incorporation techniques on disintegrant properties of wheat (Triticum aestivum) starch in metronidazole tablet formulations.
Odeniyi MA; Ayorinde JO
Polim Med; 2014; 44(3):147-55. PubMed ID: 25696939
[TBL] [Abstract][Full Text] [Related]
16. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.
Chatchawalsaisin J; Podczeck F; Newton JM
Int J Pharm; 2004 May; 275(1-2):41-60. PubMed ID: 15081137
[TBL] [Abstract][Full Text] [Related]
17. Use of к-carrageenan, chitosan and Carbopol 974P in extruded and spheronized pellets that are devoid of MCC.
Valle BL; Omwancha WS; Neau SH; Wigent RJ
Drug Dev Ind Pharm; 2016 Nov; 42(11):1903-16. PubMed ID: 27100683
[TBL] [Abstract][Full Text] [Related]
18. Physical properties of chitosan pellets produced by extrusion-spheronisation: influence of formulation variables.
Santos H; Veiga F; Pina M; Podczeck F; Sousa J
Int J Pharm; 2002 Oct; 246(1-2):153-69. PubMed ID: 12270618
[TBL] [Abstract][Full Text] [Related]
19. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
Verheyen P; Steffens KJ; Kleinebudde P
Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
[TBL] [Abstract][Full Text] [Related]
20. Functional assessment of four types of disintegrants and their effect on the spironolactone release properties.
Rojas J; Guisao S; Ruge V
AAPS PharmSciTech; 2012 Dec; 13(4):1054-62. PubMed ID: 22899380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
